BP Agents Flashcards
Blood pressure is determined by….
Heart Rate
Stroke Volume: Amount of blood pumped out of the ventricle with each heartbeat
Total Peripheral Resistance: Resistance of the muscular arteries to the blood being pumped through
Baroreceptors
Renin-Angiotensin-Aldosterone system
Renin-Angiotensin System
- Decreased perfusion pressure in the afferent arteriole stimulates secretion of renin by the juxtaglomerular cells
- Liver produces angiotensinogen
- Activation of angiotensin I to angiotensin II occurs in the pulmonary capillary bed by converting enzyme
- Angiotensin II: powerful vasoconstrictor
- Angiotensin II becomes angiotensin III which causes the release of aldosterone from the adrenal cortex
- Aldosterone causes increased sodium and water reabsorption by the tubules of the kidney. Result is increased blood volume
Risks related to hypertension
Coronary Artery Disease: thickening of the heart muscle; increased pressure generated by the muscle on contraction; increased workload of the heart CAD and Cardiac Death Stroke Loss of vision Renal failure
Normal BP
SBP <120 mm Hg and DBP <80 mm Hg
Elevated BP
SBP 120-129 mmHg and DBP <80 mm Hg
Hypertension Stage 1
SBP 130-139 mm Hg and DBP 80-89 mm Hg
Hypertension Stage 2
SBP >140 mm Hg and DBP >90 mm Hg
Factors that increase BP
High levels of psychological stress Exposure to high-frequency noise High salt diet Lack of rest Genetic predisposition
Children
Use of drugs affecting BP across the lifespan
National Standards - new
May start in childhood
More likely to be secondary
Use of drug therapy with caution
Lifestyle changes first
Follow-up needed (monitor BP, monitor for adverse effects)
Mild diuretic - monitor glucose and electrolytes
Calcium Channel Blockers
Beta blockers - adverse effects possible
NO: angiotensin receptor blockers (ARBs) and angiotensin-converting enzymes (ACEs) - no established safety
Adults
Use of drugs affecting BP across the lifespan
Education - adverse effects that should be reported immediately
Safety precautions - situations that may cause dehydration
Drug-drug interactions
Lifestyle modifications
Caution with pregnancy and lactation - ACEI/ARB/Renin inhibitors should not be used; if benefit outweighs risk, labetalol is the first choice if absolutely needed in pregnancy; drugs enter breastmilk and can cause serious adverse effects
Older Adults
Use of drugs affecting blood pressure across the lifespan
More susceptible to toxic effects
underlying conditions that may effect drug metabolism and excretion: reduced dose, close monitoring
Drug-Drug interactions including herbal therapies
Safety precautions: sustained-release or extended release medication (do not cut, crush or chew; may have a toxic dose); fall risk reduction; monitoring for dehydration; Evaluating BP (in institutional settings, BP should be taken immediately before administration)
Stepped Care Management of Hypertension
- lifestyle modifications are instituted
- Inadequate response = drug therapy added
- Inadequate response = consider change in drug dose or class or addition of another drug for combined effect
- inadequate response = second or third agent or diuretic is added if not already prescribed
Drugs affecting the RAAS
ACE Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Renin Inhibitors
Sympathetic Nervous System Blockers
Beta Blockers (selective/nonselective) Alpha Adrenergic Blockers (non selective and Alpha1 blockers) Alpha and Beta Blockers (aka nonselective adrenergic blocking agents) Alpha2 agonist
Antihypertensive agents
Drugs affecting the RAAS Calcium Channel blockers Vasodilators Diuretics Sympathetic Nervous System Blockers
ACE Inhibitors - action/indication
“-pril”
Action: Blocks ACE from converting angiotensin I to angiotensin II in the RAAS –> this blocks aldosterone leading to vasodilation, sodium and water excretion, and small increase in serum potassium
Indication: HTN; Congestive heart failure and left ventricular dysfunction (in conjunction with other meds); diabetic nephropathy prevention
Drugs: Benazepril, Captopril, Enalapril, Lisinopril, Ramipril
ACE Inhibitors - contraindications, caution, interactions, adverse effects
Contraindications: allergy; impaired renal function; pregnancy (Black box warning)
Caution: Acute/unstable CHF; african americans
Drug-Drug Interactions: Allopurinol; other drugs affecting the RAAS; NSAIDs
Adverse Effects related to vasodilation and alterations in blood flow: reflex tachycardia; hypotension;renal insufficiency; dizziness; fatigue; erectile dysfunction
Adverse effects (other): Pancytopenia; GI Irritation; Rash; Hyperkalemia; cough